[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30.
https://doi.org/10.3322/caac.21590
|
[3]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34.
https://doi.org/10.3322/caac.21551
|
[4]
|
Rahib, L., Smith, B.D., Aizenberg, R., Rosenzweig, A.B., Fleshman, J.M. and Matrisian, L.M. (2014) Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States. Cancer Research, 74, 2913-2921. https://doi.org/10.1158/0008-5472.CAN-14-0155
|
[5]
|
Sun, D., Cao, M., Li, H., et al. (2020) Cancer Burden and Trends in China: A Review and Comparison with Japan and South Korea. Chinese Journal of Cancer Research, 32, 129-139. https://doi.org/10.21147/j.issn.1000-9604.2020.02.01
|
[6]
|
杨程显, 李戈, 张立颖. 胶原蛋白IV在肿瘤领域的研究进展[J]. 重庆医学, 2015, 44(32): 4586-4589.
|
[7]
|
许婷, 杨明夏. 胶原蛋白VI在肿瘤中的作用研究进展[J]. 中国现代医学杂志, 2020, 30(14): 47-52.
|
[8]
|
周炜建, 刘超英. X型胶原蛋白在恶性肿瘤中的研究进展[J]. 现代肿瘤医学, 2020, 28(16): 2898-2901.
|
[9]
|
Nissen, N.I., Karsdal, M. and Willumsen, N. (2019) Collagens and Cancer Associated Fibroblasts in the Reactive Stroma and Its Relation to Cancer Biology. Journal of Experimental & Clinical Cancer Research, 38, Article No. 115.
https://doi.org/10.1186/s13046-019-1110-6
|
[10]
|
Shoulders, M.D. and Raines, R.T. (2009) Collagen Structure and Stability. Annual Review of Biochemistry, 78, 929-958. https://doi.org/10.1146/annurev.biochem.77.032207.120833
|
[11]
|
Kadler, K.E., Baldock, C., Bella, J. and Boot-Handford, R.P. (2007) Collagens at a Glance. Journal of Cell Science, 120, 1955-1958. https://doi.org/10.1242/jcs.03453
|
[12]
|
Provenzano, P.P., Cuevas, C., Chang, A.E., Goel, V.K., Von Hoff, D.D. and Hingorani, S.R. (2012) Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 21, 418-429. https://doi.org/10.1016/j.ccr.2012.01.007
|
[13]
|
Dangi-Garimella, S., Sahai, V., Ebine, K., Kumar, K. and Munshi, H.G. (2013) Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase Expression. PLoS ONE, 8, e64566. https://doi.org/10.1371/journal.pone.0064566
|
[14]
|
Shields, M.A., Dangi-Garimella, S., Redig, A.J., et al. (2012) Biochemical Role of the Collagen-Rich Tumour Microenvironment in Pancreatic Cancer Progression. Biochemical Journal, 441, 541-552.
https://doi.org/10.1042/BJ20111240
|
[15]
|
Hamada, S. and Masamune, A. (2018) Elucidating the Link between Collagen and Pancreatic Cancer: What’s Next? Expert Review of Gastroenterology & Hepatology, 12, 315-317. https://doi.org/10.1080/17474124.2018.1448268
|
[16]
|
Duan, W., Ma, J., Ma, Q., Xu, Q., Lei, J., Han, L., Li, X., Wang, Z., Wu, Z., Lv, S., Ma, Z., Liu, M., Wang, F. and Wu, E. (2014) The Activation of Beta1-Integrin by Type I Collagen Coupling with the Hedgehog Pathway Promotes the Epithelial- Mesenchymal Transition in Pancreatic Cancer. Current Cancer Drug Targets, 14, 446-457.
https://doi.org/10.2174/1568009614666140402105101
|
[17]
|
Huang, H., Svoboda, R.A., Lazenby, A.J., Saowapa, J., Chaika, N., Ding, K., Wheelock, M.J. and Johnson, K.R. (2016) Up-Regulation of N-Cadherin by Collagen I-Activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1. Journal of Biological Chemistry, 291, 23208-23223.
https://doi.org/10.1074/jbc.M116.740605
|
[18]
|
Torphy, R.J., Wang, Z., True-Yasaki, A., Volmar, K.E., Rashid, N., Yeh, B., Anderson, J.M., Johansen, J.S., Hollingsworth, M.A., Yeh, J.J. and Collisson, E.A. (2018) Stromal Content Is Correlated with Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma. JCO Precision Oncology, 17, Article ID: 00121.
https://doi.org/10.1200/PO.17.00121
|
[19]
|
Özdemir, B.C., Pentcheva-Hoang, T., Carstens, J.L., et al. (2014) Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival. Cancer Cell, 25, 719-734. https://doi.org/10.1016/j.ccr.2014.04.005
|
[20]
|
Madsen, C.D. (2021) Pancreatic Cancer Is Suppressed by Fibroblast-Derived Collagen I. Cancer Cell, 39, 451-453.
https://doi.org/10.1016/j.ccell.2021.02.017
|
[21]
|
Daniel, Ö., Oskar, F., Erik, L., et al. (2013) Type IV Collagen Stimulates Pancreatic Cancer Cell Proliferation, Migration, and Inhibits Apoptosis through an Autocrine Loop. BMC Cancer, 13, Article No. 154.
https://doi.org/10.1186/1471-2407-13-154
|
[22]
|
Ohlund, D., Lundin, C., Ardnor, B., et al. (2009) Type IV Collagen Is a Tumour Stroma-Derived Biomarker for Pancreas Cancer. British Journal of Cancer, 101, 91-97. https://doi.org/10.1038/sj.bjc.6605107
|
[23]
|
张元, 曹庆飞, 佟明. COL6A1高表达对肾透明细胞癌患者预后的影响[J]. 锦州医科大学学报, 2021, 42(3): 56-63.
|
[24]
|
陈佳琦. COL6A3在肾癌中的表达及临床意义[D]: [硕士学位论文]. 长春: 吉林大学, 2021.
|
[25]
|
张竞, 谢扬, 王凤, 齐健. COL6A3基因与胃癌免疫浸润水平及临床预后的相关性分析[J]. 消化肿瘤杂志(电子版), 2020, 12(4): 248-255.
|
[26]
|
郑多安, 郑漫漫, 孟翔凌, 孙登群, 孙艳军, 陈晓玲. COL6A2基因在胃癌中的表达及临床意义[J]. 武警医学, 2020, 31(9): 765-770.
|
[27]
|
谢春英. COL6A3在结直肠癌中的表达及相关临床意义[D]: [硕士学位论文]. 长春: 吉林大学, 2018.
|
[28]
|
王芃芃. Collagen VI在喉癌中筛查、鉴定及迁移粘附分子机制的研究[D]: [博士学位论文]. 沈阳: 中国医科大学, 2019.
|
[29]
|
杨荣权, 廖泽明, 蔡勇, 王超. 抑制COL6A1基因表达对膀胱癌T24细胞增殖和侵袭能力的影响[J]. 临床泌尿外科杂志, 2019, 34(6): 449-452+458.
|
[30]
|
Karamitopoulou, E. (2013) Role of Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Is Tumor Budding the Missing Link? Frontiers in Oncology, 3, Article No. 221. https://doi.org/10.3389/fonc.2013.00221
|
[31]
|
Handra-Luca, A., Hong, S.M., Walter, K., et al. (2011) Tumour Epithelial Vimentin Expression and Outcome of Pancreatic Ductal Adenocarcinomas. British Journal of Cancer, 104, 1296-1302. https://doi.org/10.1038/bjc.2011.93
|
[32]
|
Kang, C.Y., Wang, J., Axell-House, D., et al. (2014) Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Surgery, 18, 7-15. https://doi.org/10.1007/s11605-013-2326-y
|
[33]
|
Owusu-Ansah Kwabena Gyabaah. COL6A1促进胰腺癌转移及临床意义研究[D]: [博士学位论文]. 杭州: 浙江大学, 2019.
|
[34]
|
Chan, D. and Jacenko, O. (1998) Phenotypic and Biochemical Consequences of Collagen X Mutations in Mice and Humans. Matrix Biology, 17, 169-184. https://doi.org/10.1016/S0945-053X(98)90056-7
|
[35]
|
Chen, Q.A., Gibney, E., Fitch, J.M., et al. (1990) Long-Range Movement and Fibril Association of Type X Collagen within Embryonic Cartilage Matrix. Proceedings of the National Academy of Sciences of the United States of America, 87, 8046-8050. https://doi.org/10.1073/pnas.87.20.8046
|
[36]
|
Jacenko, O., LuValle, P.A. and Olsen, B.R. (1993) Spondylometaphyseal Dysplasia in Mice Carrying a Dominant Negative Mutation in a Matrix Protein Specific for Cartilage-to-Bone Transition. Nature, 365, 56-61.
https://doi.org/10.1038/365056a0
|
[37]
|
Chung, K.S., Jacenko, O., Boyle, P., et al. (1997) Craniofacial Abnormalities in Mice Carrying a Dominant Interference Mutation in Type X Collagen. Developmental Dynamics, 208, 544-552.
https://doi.org/10.1002/(SICI)1097-0177(199704)208:4%3C544::AID-AJA10%3E3.0.CO;2-X
|
[38]
|
Dublet, B., Venet, T. and van der Rest, M. (1999) Schmid’s Metaphyseal Chondrodysplasia Mutations Interfere with Folding of the C-Terminal Domain of Human Collagen X Expressed in Escherichia coli. Journal of Biological Chemistry, 274, 18909-18915. https://doi.org/10.1074/jbc.274.27.18909
|
[39]
|
陈况, 柳俨哲, 胡明根. X 型胶原蛋白在胰腺癌中的表达及与胰腺癌预后的关系[J]. 解放军医学院报, 2019, 40(4): 373-376+394.
|